Table 2.
Surveillance Year | Estimated First Recurrences | Estimated Hospitalizations | Estimated In-Hospital Deaths | |||
---|---|---|---|---|---|---|
Community-Associated CDI | Health Care-Associated CDI | Community-Associated CDI | Health Care-Associated CDI | Community-Associated CDI | Health Care-Associated CDI | |
2011 | 678 | 1959 | 1691 | 6145 | 159 | 889 |
2012 | 703 | 1848 | 2130 | 6527 | 161 | 571 |
2013 | 879 | 1665 | 2259 | 6398 | 202 | 581 |
2014 | 843 | 1690 | 2320 | 6537 | 142 | 670 |
2015 | 1066 | 1740 | 2633 | 6643 | 198 | 812 |
2016 | 1092 | 1380 | 2740 | 6024 | 190 | 750 |
2017 | 967 | 1221 | 2505 | 5483 | 164 | 573 |
The frequency of cases was weighted to account for sampling in two of the Emerging Infections Program sites (Colorado and Georgia) and sampling of health care–associated CDI cases. Recurrence refers to the first recurrent episode, defined as a positive stool specimen within 2 to 8 weeks after the initial positive test. Hospitalization includes admission on the day of or in the 6 calendar days after diagnosis of CDI. In-hospital deaths refer to deaths that occurred during hospitalization.